New Key Statistics Module, Z-Score and F-Score
NAS:SGMO Key Ratios
| Market Cap $ M | 479.89 |
| Enterprise Value $ M | 468.41 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 12.23 |
| Price/Sales | 9.31 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 52.00 |
| EPS (TTM) $ | -0.75 |
| Beneish M-Score | 16.46 |
| 10-y EBITDA Growth Rate % | -6.40 |
| 5-y EBITDA Growth Rate % | 1.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -3.49 |
| EV-to-EBITDA | -3.78 |
| PEG | -- |
| Shares Outstanding M | 208.65 |
| Net Margin (%) | -257.87 |
| Operating Margin % | -256.68 |
| Pre-tax Margin (%) | -257.89 |
| Quick Ratio | 1.35 |
| Current Ratio | 1.35 |
| ROA % (ttm) | -93.87 |
| ROE % (ttm) | -199.86 |
| ROIC % (ttm) | -183.60 |
| Dividend Yield % | -- |
| Altman Z-Score | -18.01 |
SGMO Number of Guru Trades
SGMO Volume of Guru Trades
Gurus Latest Trades with NAS:SGMO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SGMO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sangamo Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SGMO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers